The complicated effects of obesity on cancer and immunotherapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The complicated effects of obesity on cancer and immunotherapy

Published:2019-01 Issue:1 Volume:11 Page:11-14
ISSN:1750-743X
Container-title:Immunotherapy
language:en
Short-container-title:Immunotherapy

Author:

Wang Ziming¹,Monjazeb Arta M²,Murphy William J¹³

Affiliation:

1. Department of Dermatology, UC Davis School of Medicine, Sacramento, CA 95816, USA

2. Department of Radiation Oncology, UC Davis Comprehensive Cancer Center, UC School of Medicine, Sacramento, CA 95817, USA

3. Department of Internal Medicine, Division of Hematology & Oncology, UC Davis School of Medicine, Sacramento, CA 95817, USA

Publisher

Future Medicine Ltd

Subject

Oncology,Immunology,Immunology and Allergy

Link

https://www.futuremedicine.com/doi/pdf/10.2217/imt-2018-0133

Reference20 articles.

1. Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma

2. Pembrolizumab for the Treatment of Non–Small-Cell Lung Cancer

3. MPDL3280A (anti-PD-L1) treatment leads to clinical activity in metastatic bladder cancer

4. CAR T cell immunotherapy for human cancer

5. Oncolytic viruses: a new class of immunotherapy drugs

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical variables associated with immune checkpoint inhibitor outcomes in patients with metastatic urothelial carcinoma: a multicentre retrospective cohort study;BMJ Open;2024-03

2. Prognostic utility of body composition parameters based on computed tomography analysis of advanced non-small cell lung cancer treated with immune checkpoint inhibitors;Insights into Imaging;2023-10-26

3. Clinical variables associated with immune checkpoint inhibitor outcomes in patients with metastatic urothelial carcinoma;2023-10-04

4. The obesity-breast cancer link: a multidisciplinary perspective;Cancer and Metastasis Reviews;2022-06-25

5. Help or hindrance: The obesity paradox in cancer treatment response;Cancer Letters;2021-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3